Delcath Systems Stock

Delcath Systems EBITDA per Share

The EBITDA per Share of Delcath Systems (DCTH) as of Aug 4, 2026 is 0.02 USD. In the previous year, EBITDA per Share was -0.44 USD — a change of -103.80% (higher).

EBITDA per Share

0.02USD

YoY

-103.80%

Last updated:

EBITDA per Share of Delcath Systems is 2026 0.02 USD. EBITDA per Share of Delcath Systems was 2025 -0.44 USD. It decreases by -103.80% higher compared to the previous year.
Access this data via the Eulerpool API

Delcath Systems Stock analysis

What does Delcath Systems do? Delcath Systems Inc is a US-American medical technology company specializing in the development of innovative products for the treatment of various forms of liver cancer. The company was founded in 1988 in New York and is headquartered in Queensbury today. Delcath Systems is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Delcath Systems stock

EBITDA per Share of Delcath Systems is 0.02 USD in 2026.

EBITDA per Share of Delcath Systems changed from -0.44 USD to 0.02 USD, representing a -103.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Delcath Systems since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

Income Statement — Delcath Systems

All Key Metrics — Delcath Systems